EUVIMEDEUVIMED entdecken
Crossref

Comparative Clinical Evaluation of Saraswata Churna and Kalyanaka Ghrita Along with Satvavajaya Chikitsa in Pediatric Gaming Disorder: A Randomized Study

Manpreeth Mali Patil, Durga Prasad Dash

International Journal of Drug Delivery Technology · 04.06.2026 · 16 (46s)

DOI: 10.25258/ijddt.16.46s.70 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.06.2026. Verfasst von Manpreeth Mali Patil und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gaming Disorder (GD) has been officially recognized by the World Health Organization in ICD-11 as a significant mental health condition affecting adolescents worldwide. Characterized by impaired control over gaming behaviors, increasing priority given to gaming over daily activities, and continuation despite negative consequences, GD affects approximately 10-15% of young people in Asian countries, with highest prevalence among male adolescents aged 12-20 years. Current pharmacological interventions including Bupropion and Methylphenidate present significant side effect profiles, necessitating exploration of safer therapeutic alternatives. Ayurveda offers promising interventions through Medhya Rasayana (nootropic rejuvenators) and Satvavajaya Chikitsa (Ayurveda psychotherapy). Aim: To comparatively evaluate the efficacy of Saraswata Churna with Kalyanaka Ghrita as Anupana combined with Satvavajaya Chikitsa versus Satvavajaya Chikitsa alone in reducing Gaming Disorder severity among children aged 12-16 years. A randomized, comparative, open-label clinical trial was conducted on 100 participants (50 per group) meeting ICD-11 diagnostic criteria for Gaming Disorder. Group A received Saraswata Churna (6-7g twice daily based on age) with Kalyanaka Ghrita (as Anupana) and Satvavajaya Chikitsa (8 sessions for 60 days). Group B received Satvavajaya Chikitsa alone. Treatment duration was 60 days with follow-up at 90 days. Primary outcome was reduction in Internet Gaming Disorder Scale-Short Form (IGDS-SF9) scores. Secondary outcomes included Depression, Anxiety and Stress Scale (DASS-21) scores and assessment of Dhee, Dhriti, Smriti Vibhramsha (cognitive, volitional and memory impairments). Group A demonstrated statistically significant superiority over Group B in all outcome measures. Mean IGDS-SF9 reduction was 33.39% in Group A versus 18.97% in Group B at day 90 (p

Zitieren

APA

Patil, M. M., & Dash, D. P. (2026). Comparative Clinical Evaluation of Saraswata Churna and Kalyanaka Ghrita Along with Satvavajaya Chikitsa in Pediatric Gaming Disorder: A Randomized Study. International Journal of Drug Delivery Technology, 16(46s). https://doi.org/10.25258/ijddt.16.46s.70

Vancouver

Patil MM, Dash DP. Comparative Clinical Evaluation of Saraswata Churna and Kalyanaka Ghrita Along with Satvavajaya Chikitsa in Pediatric Gaming Disorder: A Randomized Study. International Journal of Drug Delivery Technology. 2026;16(46s). doi:10.25258/ijddt.16.46s.70

BibTeX
@article{Patil2026,
  author = {Patil, Manpreeth Mali and Dash, Durga Prasad},
  title = {Comparative Clinical Evaluation of Saraswata Churna and Kalyanaka Ghrita Along with Satvavajaya Chikitsa in Pediatric Gaming Disorder: A Randomized Study},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {46s},
  doi = {10.25258/ijddt.16.46s.70}
}
Kostenlos starten →